Terms: = Breast cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Treatment
22 results:
1. The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials.
Ge A; Yang K; Deng X; Zhao D; Ge J; Liu L
J Ethnopharmacol; 2022 Sep; 295():115357. PubMed ID: 35545184
[TBL] [Abstract] [Full Text] [Related]
2. fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
[TBL] [Abstract] [Full Text] [Related]
3. Signaling Crosstalk of fhit, p53, and p38 in etoposide-induced apoptosis in MCF-7 cells.
Khedri A; Khaghani S; Kheirollah A; Babaahmadi-Rezaei H; Shadboorestan A; Zangooei M; Afra HS; Meshkani R; Ghahremani MH
J Cell Biochem; 2019 Jun; 120(6):9125-9137. PubMed ID: 30614034
[TBL] [Abstract] [Full Text] [Related]
4. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract] [Full Text] [Related]
5. Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
Le Saux O; Bourmaud A; Rioufol C; Colomban O; Guitton J; Schwiertz V; Regnier V; You B; Ranchon F; Maraval-Gaget R; Girard P; Chauvin F; Freyer G; Tod M; Henin E; Trillet-Lenoir V
Cancer Chemother Pharmacol; 2018 Aug; 82(2):319-327. PubMed ID: 29948022
[TBL] [Abstract] [Full Text] [Related]
6. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
Olov N; Bagheri-Khoulenjani S; Mirzadeh H
J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
[TBL] [Abstract] [Full Text] [Related]
7. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract] [Full Text] [Related]
8. DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and breast cancer (WEB) study.
Callahan CL; Wang Y; Marian C; Weng DY; Eng KH; Tao MH; Ambrosone CB; Nie J; Trevisan M; Smiraglia D; Edge SB; Shields PG; Freudenheim JL
Epigenetics; 2016 Sep; 11(9):643-652. PubMed ID: 27245195
[TBL] [Abstract] [Full Text] [Related]
9. The clinicopathological significance and drug target potential of fhit in breast cancer, a meta-analysis and literature review.
Su Y; Wang X; Li J; Xu J; Xu L
Drug Des Devel Ther; 2015; 9():5439-45. PubMed ID: 26491255
[TBL] [Abstract] [Full Text] [Related]
10. Malignant phyllodes tumour of the breast.
Badar F; Mahmood S; Syed AA; Siddiqui N
J Ayub Med Coll Abbottabad; 2012; 24(3-4):47-9. PubMed ID: 24669607
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K
Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451
[TBL] [Abstract] [Full Text] [Related]
12. Study of fhit and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract] [Full Text] [Related]
13. [Promoter hypermethylation gene patterns in gynecological tumors].
Leal Rojas P; Anabalón Rodríguez L; García Muñoz P; Tapia Escalona O; Guzmán González P; Araya Orostica JC; Villaseca Hernández M; Roa Strauch JC
Med Clin (Barc); 2009 Mar; 132(10):371-6. PubMed ID: 19268989
[TBL] [Abstract] [Full Text] [Related]
14. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
[TBL] [Abstract] [Full Text] [Related]
15. Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy.
Oudin C; Bonnetain F; Boidot R; Végran F; Soubeyrand MS; Arnould L; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2007 May; 30(5):1145-51. PubMed ID: 17390016
[TBL] [Abstract] [Full Text] [Related]
16. Fragile genes as biomarkers: epigenetic control of WWOX and fhit in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract] [Full Text] [Related]
17. Loss of fhit protein expression is a marker of adverse evolution in good prognosis localized breast cancer.
Ginestier C; Bardou VJ; Popovici C; Charafe-Jauffret E; Bertucci F; Geneix J; Adélaïde J; Chaffanet M; Hassoun J; Viens P; Jacquemier J; Birnbaum D
Int J Cancer; 2003 Dec; 107(5):854-62. PubMed ID: 14566838
[TBL] [Abstract] [Full Text] [Related]
18. [Progress in surgical treatment may improve the quality of life in patients with breast surgery for malignant tumors].
Málek J; Kurzová A; Vedral T; Pelák Z; Ambrus M
Rozhl Chir; 2003 Feb; 82(2):83-7. PubMed ID: 12712906
[TBL] [Abstract] [Full Text] [Related]
19. fhit: from gene discovery to cancer treatment and prevention.
Pekarsky Y; Zanesi N; Palamarchuk A; Huebner K; Croce CM
Lancet Oncol; 2002 Dec; 3(12):748-54. PubMed ID: 12473516
[TBL] [Abstract] [Full Text] [Related]
20. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract] [Full Text] [Related]
[Next]
